Corporate Profile

Aeterna Zentaris Inc. (TSX: AEZ, NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health.

Contact us:

Aeterna Zentaris, Inc.
315 Sigma Drive, Suite 302D
Summerville, SC 29483
Phone: (843) 900-3223

Aeterna Zentaris GmbH
Weismüllerstrasse 50
60314 Frankfurt
Phone: +49 69 42602 3228

Aeterna Zentaris Inc.
1405 du Parc-Technologique Blvd.
Québec, Québec
G1P 4P5
Phone: (418) 652-8525
Fax: (418) 948-9191

Aeterna Zentaris Announces Special Meeting of Shareholders and Mailing of Management Information Circular more...>

Aeterna Zentaris: Data and Safety Monitoring Board Recommends Continuation of ZoptEC Phase 3 Trial in Advanced Endometrial Cancer more...>

Aeterna Zentaris Announces Restructuring of Finance & Accounting Operations and Closure of Quebec City Office more...>

Aeterna Zentaris’ Zoptarelin Doxorubicin Meets Phase 2 Primary Endpoint in Men with Heavily Pretreated Castration and Taxane Resistant Prostate Cancer more...>

Aeterna Zentaris Announces TSX Approval of Series B Warrant Amendment more...>
September 9, 2015
Rodman & Renshaw Annual Growth Conference
10:25 a.m., Eastern Time


Download PDF (125K)
Download and install Acrobat Reader